Genetic polymorphism of 5,10-Methylenetetrahydrofolate Reductase C677T in Kashmiri population

Biotechnology

Volumn 7, Issue 4, 2008, Pages 822-825

  Bhat, T A ^a   Mir, M R ^a   Qasim, I ^a   Misra, S S ^a   Kirmani, M A ^a  

^a SHER E KASHMIR UNIVERSITY OF AGRICULTURAL SCIENCES AND TECHNOLOGY OF KASHMIR   (India)

Author keywords

5,10 methylentetrahydrofolate reductase; Atherosclerosis; C677T; Homocysteine; PCR RFLP

Indexed keywords

5,10-METHYLENTETRAHYDROFOLATE REDUCTASE; ATHEROSCLEROSIS; C677T; HOMOCYSTEINE; PCR-RFLP;

DECISION MAKING; RISK PERCEPTION;

POLYMORPHISM;

EID: 67651046677     PISSN: 1682296X     EISSN: 16822978     Source Type: Journal    
DOI: 10.3923/biotech.2008.822.825     Document Type: Article

References (18)

1. Boushey, C. J., S. A. Beresford, G. S. Omenn and A. G. Motulsky, 1995. Probable benefits of increasing folic acid intakes. J. Am. Med. As social., 274:1049-1057.
2. Denheijer, M., T. Koster, H. J. J. Blom, G. M. Bos and E. Briet et al., 1996. For deep-vein thrombosis. N. Eng. J. Med, 334:759-762.
3. Friedman, G., N. Goldschmidt, Y. Friedlander, A. Ben-Yehuda and J. Selhub et al., 1999. Methylenetetrahydrofolate reductase gene
4. polymorphisms and the risk of anencephaly in Mexico. J. Nutr., 129:1656-1661.
5. Frosst, P., H. J. Blom, R. Milos, P. Goyette and C. A. Sheppard et al., 1995. A candidate genetic. Nat. Genet, 10:111-113.
6. Giles, W. H., S. J. Kittner and O. Chin-Yih et al., 1998. Thermolabile methylenetetrahydrofolate reductase polymorphism (C677T) and total homocysteine concentration among African, American and white women. Ethnicity Dis., 8:149-157.
7. Girelli, F., S. Literati, R. Percacci and C. Rahmede, 1998. An example may be the correlation between low serum folate and MTHFR gene mutation C677T in determining hyperhomo. Cysteinemia, 45:395-397.
8. Kang, S. S., J. Zhou, P. W. K. Wong, J. Kowalisyn and G. Strokosch, 1988. Variant of methylenetetrahydrofolate reductase. Am. J. Hum. Genet, 43:414-421.
9. Lievers, K. J., G. H. Boers and P. Verhoef et al., 2006. A 2nd common variant in the methylenetetra-hydrofolate reductase (mthfr). J. Inherited Metabolic Dis., 29:3-20.
10. Lorenzo, D. B. and Y. Quanhe, 2000. 5, 10-methylenetetrahydrofolate reductase (mthfr) 677 c®t genetic. Am. J. Epidemiol., 151:862-877.
11. Madonna, P., I. Fermo, A. Pagano and G. Mazzola et al., 2002. Hyperhomocysteinemia, MTHFR 677C->T Polymorphism and Stroke. Stroke, 33:51-56.
12. Mcquillan, B., J. P. Beilby, M. Nidorf, P. Lthompson and J. Hung, 1999. Disease assessment study (cudas). Circulation, 99:2383-2388.
13. Refsum, H., P. M. Ueland, O. Nygård and S. E. Vollset, 1998. Homocysteine and cardiovascular disease. Annu. Rev. Med., 49:31-62.
14. Robinson, K., K. Arheart, H. Refsum, I. Brattstrom and G. Boers et al., 1998. Common methylenetetrahydrofolate reductase. Circulation, 97:437-443.
15. Shaw, G. M., R. Rozen, R. H. Finnell, C. R. Wasserman and E. J. Lammer, 1998. Maternal vitamin use, genetic variation. Am. J. Epidemiol., 148:30-37.
16. Toffoli, G., R Gafa, A. Russo, G. Lanza and R. Dolcetti et al., 2003. Colon cancer in North Italy. Clin. Cancer Res., 9:743-748.
17. Ueland, P. M., H. Refsum and L. Brattstrom, 1992. Plasma Homocysteine and Cardiovascular Disease. In: Atherosclerotic Cardiovascular Disease, Hemostatis and Endothelial Function, Francis, R. B. Jr. (Ed.). Dekker, New York, pp:183-236.
18. Wilcken, D. E., 1998. Novel risk factors for vascular disease: The homocysteine hypothesis of cardiovascular disease. J. Cardiovasc. Risk, 5:217-221.